Research Advances and Clinical Impact of New Data From Crohn’s & Colitis Congress® 2019 *

February 7-9, 2019; Las Vegas, Nevada
Review expert commentary of key data from the 2019 Crohn’s and Colitis Congress

Share

Program Content

Activities

Monitoring in IBD
Disease and Drug Monitoring in IBD: My Take on Data From Crohn’s & Colitis Congress 2019
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2019

Expires: June 05, 2020

New and Emerging Therapy
New and Emerging IBD Treatments: Our Take on Data From Crohn’s & Colitis Congress 2019
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2019

Expires: June 24, 2020

Supporters

Supported by educational grants from

Celgene without Corporation

Takeda Pharm USA

Partners

AGA CCF

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.